1-20 of 31
Violeta Sánchez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B007: Identification of Asporin as a HER3 ligand exposes a therapeutic vulnerability in metastatic prostate cancer

Amanda B. Hesterberg, Hong Yuen Wong, Jorgen Jackson, Monika Antunovic, Brenda L. Rios, Evan Watkins, Riley E. Bergman, Brad A. Davidson, Sarah E. Ginther, Diana Graves, Elliott F. Nahmias, Jared A. Googel, Lillian B. Martin, Violeta Sanchez, Paula Gonzalez Ericsson, Quanhu Sheng, Benjamin P. Brown, Jens Meiler, Ben H. Park, Kerry R. Schaffer, Jennifer B. Gordetsky, Paula J. Hurley
Journal: Cancer Research
Cancer Res (2024) 84 (22_Supplement): B007.
https://doi.org/10.1158/1538-7445.TUMBODY-B007
Published: 17 November 2024
View articletitled, Abstract B007: Identification of Asporin as a HER3 ligand exposes a therapeutic vulnerability in metastatic prostate cancer
Journal Articles

Abstract PO3-02-03: Ketogenic diet and letrozole to inhibit PI3K signaling in ER+ breast cancer

Brent Rexer, Vandana Abramson, Sara Nunnery, Sonya Reid, Laura Kennedy, Melinda Sanders, Jessica Bennett, Paula Gonzalez-Ericsson, Violeta Sanchez
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO3-02-03.
https://doi.org/10.1158/1538-7445.SABCS23-PO3-02-03
Published: 02 May 2024
View articletitled, Abstract PO3-02-03: Ketogenic diet and letrozole to inhibit PI3K signaling in ER+ breast cancer
Journal Articles

Abstract 2726: Host myeloid response drives anti-PD-L1 resistance in murine models of triple negative breast cancer

Ann Hanna, Xiaopeng Sun, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Justin M. Balko
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2726.
https://doi.org/10.1158/1538-7445.AM2022-2726
Published: 15 June 2022
View articletitled, Abstract 2726: Host myeloid response drives anti-PD-L1 resistance in murine models of triple negative breast cancer
Journal Articles

Abstract PS4-19: Evaluation of tumor-specific MHC-II expression as a biomarker

Paula Ines Gonzalez Ericsson, Justin M Balko, Violeta Sanchez, Melinda Sanders
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS4-19.
https://doi.org/10.1158/1538-7445.SABCS20-PS4-19
Published: 15 February 2021
View articletitled, Abstract PS4-19: Evaluation of tumor-specific MHC-II expression as a biomarker
Journal Articles

Abstract PS17-14: Evaluating the efficacy of immunotherapy in triple negative breast cancer

Ann Hanna, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Melinda E. Sanders, Justin M. Balko
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS17-14.
https://doi.org/10.1158/1538-7445.SABCS20-PS17-14
Published: 15 February 2021
View articletitled, Abstract PS17-14: Evaluating the efficacy of immunotherapy in triple negative breast cancer
Journal Articles

Abstract PD5-07: The immune landscape of residual triple-negative breast cancers after neoadjuvant chemotherapy

Paula I Gonzalez-Ericsson, Violeta Sanchez, Roberto Salgado, Jennifer Bordeaux, Ju Y Kim, Christine Vaupel, Henry Gomez, Melinda E Sanders, Justin M Balko
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD5-07.
https://doi.org/10.1158/1538-7445.SABCS19-PD5-07
Published: 15 February 2020
View articletitled, Abstract PD5-07: The immune landscape of residual triple-negative breast cancers after neoadjuvant chemotherapy
Journal Articles

Abstract P3-08-15: Immunologic correlates of long-term outcome in the residual disease of triple-negative breast cancer after neoadjuvant chemotherapy

Justin M Balko, Mellissa Nixon, Paula I Gonzalez-Ericsson, Mark A Pilkinton, Wyatt J McDonnell, Violeta Sanchez, Susan R Opalenik, Sherene Loi, Brent Rexer, Vandana Abramson, Valerie Jansen, Simon Mallal, Jonathan D Marotti, Kevin Shee, Todd W Miller, Melinda E Sanders, Ingrid A Mayer, Roberto Salgado
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P3-08-15.
https://doi.org/10.1158/1538-7445.SABCS19-P3-08-15
Published: 15 February 2020
View articletitled, Abstract P3-08-15: Immunologic correlates of long-term outcome in the residual disease of triple-negative breast cancer after neoadjuvant chemotherapy
Journal Articles

Abstract 4978: Digital spatial profiling of molecular responses to nanoparticle STING agonists identify S100A9 and B7-H3 as possible escape mechanisms

John T. Wilson, Daniel Shae, Paula I. Gonzalez-Ericsson, Violeta Sanchez, JingJing Gong, Yan Liang, Douglas Hinerfeld, Joseph M. Beechem, Justin M. Balko
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4978.
https://doi.org/10.1158/1538-7445.AM2019-4978
Published: 01 July 2019
View articletitled, Abstract 4978: Digital spatial profiling of molecular responses to nanoparticle STING agonists identify S100A9 and B7-H3 as possible escape mechanisms
Journal Articles

Abstract 1511: MEK activation modulates immunosuppressive MDSCs and metabolic phenotypes in TNBC

Derek A. Franklin, Joe T. Sharick, Paula I. Ericsson-Gonzalez, Violeta Sanchez, Phillip T. Dean, Susan R. Opalenik, Stefano Cairo, Jean-Gabriel Judde, Michael T. Lewis, Jenny C. Chang, Melinda E. Sanders, Rebecca S. Cook, Melissa C. Skala, Jennifer Bordeaux, Jehovana Orozco Bender, Christine Vaupel, Gary Geiss, Douglas Hinerfeld, Justin M. Balko
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1511.
https://doi.org/10.1158/1538-7445.AM2019-1511
Published: 01 July 2019
View articletitled, Abstract 1511: MEK activation modulates immunosuppressive MDSCs and metabolic phenotypes in TNBC
Journal Articles

Correction: Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer

Ariella B. Hanker, Mónica Valeria Estrada, Giampaolo Bianchini, Preston D. Moore, Junfei Zhao, Feixiong Cheng, James P. Koch, Luca Gianni, Darren R. Tyson, Violeta Sánchez, Brent N. Rexer, Melinda E. Sanders, Zhongming Zhao, Thomas P. Stricker, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2019) 79 (4): 873.
https://doi.org/10.1158/0008-5472.CAN-18-4085
Published: 15 February 2019
View articletitled, Correction: Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer
Open the PDF for Correction: Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer in another window
Journal Articles

Correction: Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Valerie M. Jansen, Neil E. Bhola, Joshua A. Bauer, Luigi Formisano, Kyung-Min Lee, Katherine E. Hutchinson, Agnieszka K. Witkiewicz, Preston D. Moore, Mónica Valéria Estrada, Violeta Sánchez, Paula G. Ericsson, Melinda E. Sanders, Paula R. Pohlmann, Michael J. Pishvaian, David A. Riddle, Teresa C. Dugger, Wenyi Wei, Erik S. Knudsen, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2019) 79 (4): 874.
https://doi.org/10.1158/0008-5472.CAN-18-4086
Published: 15 February 2019
View articletitled, Correction: Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer
Open the PDF for Correction: Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer in another window
Journal Articles

Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1

Thomas A. Werfel, David L. Elion, Bushra Rahman, Donna J. Hicks, Violeta Sanchez, Paula I. Gonzales-Ericsson, Mellissa J. Nixon, Jamaal L. James, Justin M. Balko, Peggy A. Scherle, Holly K. Koblish, Rebecca S. Cook
Journal: Cancer Research
Cancer Res (2019) 79 (1): 171–182.
https://doi.org/10.1158/0008-5472.CAN-18-1106
Published: 02 January 2019
View articletitled, Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1
Open the PDF for Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1 in another window
Includes: Supplementary data
Journal Articles

Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers

David L. Elion, Max E. Jacobson, Donna J. Hicks, Bushra Rahman, Violeta Sanchez, Paula I. Gonzales-Ericsson, Olga Fedorova, Anna M. Pyle, John T. Wilson, Rebecca S. Cook
Journal: Cancer Research
Series: Author Choice
Cancer Res (2018) 78 (21): 6183–6195.
https://doi.org/10.1158/0008-5472.CAN-18-0730
Published: 01 November 2018
View articletitled, Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers
Open the PDF for Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers in another window
Includes: Supplementary data
Journal Articles

Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival

Thomas A. Werfel, Shan Wang, Meredith A. Jackson, Taylor E. Kavanaugh, Meghan Morrison Joly, Linus H. Lee, Donna J. Hicks, Violeta Sanchez, Paula Gonzalez Ericsson, Kameron V. Kilchrist, Somtochukwu C. Dimobi, Samantha M. Sarett, Dana M. Brantley-Sieders, Rebecca S. Cook, Craig L. Duvall
Journal: Cancer Research
Cancer Res (2018) 78 (7): 1845–1858.
https://doi.org/10.1158/0008-5472.CAN-17-2388
Published: 01 April 2018
View articletitled, Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival
Open the PDF for Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival in another window
Includes: Supplementary data
Journal Articles

Abstract 3890: Mitochondrial MCL1 maintains triple negative breast cancer stem cells and contributes to chemotherapy resistance

Kyung-min Lee, Jennifer Giltnane, Justin Balko, Luis Schwarz, Angel Guerrero, Katie Hutchinson, Mellissa Hicks, Violeta Sanchez, Melinda Sanders, Taekyu Lee, Edward Olejniczak, Stephen Fesik, Carlos Arteaga
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3890.
https://doi.org/10.1158/1538-7445.AM2017-3890
Published: 01 July 2017
View articletitled, Abstract 3890: Mitochondrial MCL1 maintains triple negative breast cancer stem cells and contributes to chemotherapy resistance
Journal Articles

Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer

Ariella B. Hanker, Mónica Valeria Estrada, Giampaolo Bianchini, Preston D. Moore, Junfei Zhao, Feixiong Cheng, James P. Koch, Luca Gianni, Darren R. Tyson, Violeta Sánchez, Brent N. Rexer, Melinda E. Sanders, Zhongming Zhao, Thomas P. Stricker, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2017) 77 (12): 3280–3292.
https://doi.org/10.1158/0008-5472.CAN-16-2808
Published: 14 June 2017
View articletitled, Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer
Open the PDF for Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Valerie M. Jansen, Neil E. Bhola, Joshua A. Bauer, Luigi Formisano, Kyung-Min Lee, Katherine E. Hutchinson, Agnieszka K. Witkiewicz, Preston D. Moore, Mónica Valéria Estrada, Violeta Sánchez, Paula G. Ericsson, Melinda E. Sanders, Paula R. Pohlmann, Michael J. Pishvaian, David A. Riddle, Teresa C. Dugger, Wenyi Wei, Erik S. Knudsen, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2017) 77 (9): 2488–2499.
https://doi.org/10.1158/0008-5472.CAN-16-2653
Published: 30 April 2017
View articletitled, Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer
Open the PDF for Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers

Meghan Morrison Joly, Donna J. Hicks, Bayley Jones, Violeta Sanchez, Monica Valeria Estrada, Christian Young, Michelle Williams, Brent N. Rexer, Dos D. Sarbassov, William J. Muller, Dana Brantley-Sieders, Rebecca S. Cook
Journal: Cancer Research
Cancer Res (2016) 76 (16): 4752–4764.
https://doi.org/10.1158/0008-5472.CAN-15-3393
Published: 14 August 2016
View articletitled, Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers
Open the PDF for Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers in another window
Includes: Supplementary data
Journal Articles

Abstract 302: ECM/Integrin signaling promotes resistance to the combination of HER2 and PI3K inhibitors in HER2+, PIK3CA-mutant breast cancer

Ariella B. Hanker, Monica Valeria Estrada, Junfei Zhao, Feixiong Cheng, Preston D. Moore, Darren Tyson, Violeta Sanchez, Brent N. Rexer, Melinda Sanders, Zhongming Zhao, Thomas P. Stricker, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 302.
https://doi.org/10.1158/1538-7445.AM2016-302
Published: 15 July 2016
View articletitled, Abstract 302: ECM/Integrin signaling promotes resistance to the combination of HER2 and PI3K inhibitors in HER2+, PIK3CA-mutant breast cancer
Journal Articles

Abstract 4237: Decreased hypoxia in a HER2+ breast cancer model following trastuzumab therapy

Anna G. Sorace, C. Chad Quarles, Violeta Sanchez, Thomas E. Yankeelov
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4237.
https://doi.org/10.1158/1538-7445.AM2016-4237
Published: 15 July 2016
View articletitled, Abstract 4237: Decreased hypoxia in a HER2+ breast cancer model following trastuzumab therapy